EMEA-002741-PIP01-20-M02 - paediatric investigation plan
Fordadistrogene movaparvovec
PIPHuman
Key facts
- Active Substance
- Fordadistrogene movaparvovec
- Therapeutic area
- Congenital, familial and genetic disorders
- Decision number
- P/0073/2024
- PIP number
- EMEA-002741-PIP01-20-M02
- Pharmaceutical form(s)
- Concentrate for solution for infusion
- Condition(s) / indication(s)
- Treatment of Duchenne muscular dystrophy
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Pfizer Europe MA EEIG
E-mail: medical.information@pfizer.com
Tel. +44 1304646607- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date